-Reuters
Merck & Co Q4 Adj. EPS $1.62 Beats $1.54 Estimate, Sales $13.80B Beat $13.67B Estimate
Merck & Co (NYSE:MRK) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.54 by 5.19 percent. This is a 10 percent decrease over earnings of $1.80 per share from the same period